Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Medical Journal of Indonesia Indonesian Journal of Cancer Indonesian Journal of Obstetrics and Gynecology (Majalah Obstetri dan Ginekologi Indonesia)
Laila Nuranna
Faculty of Medicine University of Indonesia Jakarta
Health Professions Medicine & Pharmacology Public Health

Published : 22 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 22 Documents
Search

 1   2   3 
Extending Coverage and Developing a Network for Achieving Cervical Cancer Screening with Documentation on Visual Inspection of Acetic Acid (Do-VIA) in Indonesia Laila Nuranna Nuranna, Laila
Indonesian Journal of Obstetrics and Gynecology Volume. 2, No. 2, April 2014
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32771/inajog.v31i3.1082

Abstract

N/A
The SDGs Perspective of TeleDoVIA Reliability for Cervical Cancer Elimination in 2030: A Cross Sectional Study in Indonesia Widya Utami, Tofan; Nuranna, Laila; Purwoto, Gatot; Winarto, Hariyono; Fitriyadi Kusuma; Rizky Humairah , Inas; Faisha Rahma, Melly; Kekalih, Aria; Peters, Alexander AW
Indonesian Journal of Obstetrics and Gynecology Volume 12 No. 4 October 2024
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32771/inajog.v12i4.1956

Abstract

Objective: To describe the prevalence of HPV infection in women with negative Visual Inspection with Acetic Acid (VIA) and introduce Teleconsultation of Documented VIA (TeleDoVIA) as an objective test and provide a rationalization for recommending TeleDoVIA as a “high-performance” test for cervical cancer screening in lower resource settings, from SDGs perspective, to accelerate the achievement of second pillar elimination and the third SDGs target in 2030. Methods: This is a 7-year cross-sectional study. Subjects were recruited consecutively from several public and private health providers in Jakarta. VIA test was documented and consulted to the experts panel (TeleDoVIA). Negative VIA women underwent HPV-DNA testing using SPF10-DEIA-LiPA25 for PCR and electrophoresis. Results: A total of 1,397 negative VIA subjects were collected, consist of 52 HPV-DNA positive. False-negative of VIA was 3.7% (95% CI 0.027–0.047). Conclusion: VIA is a reliable screening method with a low false-negative rate. TeleDoVIA could be recommended as a reliable cervical cancer screening method in low resource settings such as Indonesia, which is in line with the third SDG: good health and well-being. Keywords: Southeast Asia < Asia; public health.
Co-Authors Abdul B. Saifuddin Abdullah, Iftikar Achmad Tjarta Aldri Frinaldi Alexander AW Peters Andriansyah Andriansyah Andrijono Andrijono Aria Kekalih Bambang Sutrisna Budiningsih Siregar Daud, Sulaeman Dewi Wulandari Dharmeizar Dharmeizar Faisha Rahma, Melly Fitriyadi Kusuma Gatot Purwoto Gita Pratama Gregorius Tanamas Harahap, Alida Roswita Hariyono Winarto Imam Rasjidi Jamhari Jamhari Jamtani, Mona Jasmine Iskandar Kayika, I. Putu G. Kusuma, Sang A F Adi Lestari, Linda Lestari, Linda M. F. Aziz Mpu Kanoko Nana Supriana Nuryanto, Kartiwa H Pelupessy, Nugraha Utama Rahma Prastasari Rizal Sanif Rizky Humairah , Inas Rochani Rochani Rukmini T. Mangunkusumo Santoso Cornain Sigit Purbadi Sylvia D Elvira Tofan W Utami Widya Utami, Tofan